Full Text
The Economic Burden Of Dasatinib And Nilotinib Treatment Failure In Chronic Myeloid Leukemia (Cml) Patients- A Real-World Analysis

Abstract

Authors

S.M. Pokras V. Divino C.P. Ferrufino Arnold R.J.G. H. Huang

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×